ARCHIVES

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Needs Staff, Funds But first Must Determine Priorities, GAO Says

November 17, 1989

New Therapeutic Approaches Improve Palliative Care

June 27, 2003

The Varmus Era: Controversy Continues

January 6, 1995

Gerald Murphy To Leave Cancer Society Sept. 1 To Direct Foundation

April 23, 1993

The Cancer Letter To End Print Edition In January

November 20, 2009

Viral Oncology Not Losing $5 Mil. This Year – But Watch Out for ‘79

January 6, 1978